Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Hurlock David

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/11/2017

3. Issuer Name and Ticker or Trading Symbol

HEALTHCARE SERVICES GROUP INC [HCSG]

(Last) (First) (Middle)

3220 TILLMAN DRIVE, SUITE 300

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Executive Vice President & COO /

(Street)

BENSALEM, PA 19020

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	3884	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Phantom Stock ⁽¹⁾	⁽²⁾	⁽²⁾	Common Stock	5848.0	$0.0	D
Restricted Stock	⁽³⁾	⁽³⁾	Common Stock	70.0	$0.0	D
Restricted Stock	⁽⁴⁾	⁽⁴⁾	Common Stock	250.0	$0.0	D
Restricted Stock	⁽⁵⁾	⁽⁵⁾	Common Stock	675.0	$0.0	D
Restricted Stock	⁽⁶⁾	⁽⁶⁾	Common Stock	1200.0	$0.0	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	1500.0	$0.0	D
Stock Option (right to buy)	⁽⁸⁾	1/4/2023	Common Stock	5000.0	$23.5	D
Stock Option (right to buy)	⁽⁹⁾	1/3/2024	Common Stock	6250.0	$28.02	D
Stock Option (right to buy)	⁽¹⁰⁾	1/5/2025	Common Stock	7500.0	$30.3	D
Stock Option (right to buy)	⁽¹¹⁾	1/4/2026	Common Stock	7500.0	$34.14	D
Stock Option (right to buy)	⁽¹²⁾	1/4/2027	Common Stock	7500.0	$39.38	D

Explanation of Responses:
(1)	Acquired pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.
(2)	Shares of Phantom Stock are payable in-kind following termination of the Reporting Person's employment with Issuer.
(3)	These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2013 grant date, and as such, 280 of these awards have already vested.
(4)	These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date, and as such, 375 of these awards have already vested.
(5)	These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date, and as such, 450 of these awards have already vested.
(6)	These Restricted Stock Awards shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date, and as such, 300 of these awards have already vested.
(7)	These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.
(8)	These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2013 grant date.
(9)	These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 3, 2014 grant date.
(10)	These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 5, 2015 grant date.
(11)	These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2016 grant date.
(12)	These options shall vest and become exercisable at the rate of 20% annually, commencing on the first anniversary of the January 4, 2017 grant date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Hurlock David 3220 TILLMAN DRIVE SUITE 300 BENSALEM, PA 19020			Executive Vice President & COO

Signatures
John C. Shea, by Power of Attorney		7/21/2017
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.